| Literature DB >> 25103146 |
Nancy H Puttkammer1, Steven B Zeliadt2, Jean Gabriel Balan3, Janet G Baseman2, Rodney Destiné3, Jean Wysler Domerçant4, Jean Marie Duvilaire5, Nernst Atwood Raphael3, Kenneth Sherr6, Krista Yuhas7, Scott Barnhart8.
Abstract
BACKGROUND: On January 12, 2010, a devastating 7.0 magnitude earthquake struck the West Department of Haiti, killing more than 200,000 people and injuring or displacing many more. This disaster threatened continuity of HIV care and treatment services.Entities:
Keywords: HIV/AIDS; Haiti; antiretroviral therapy; attrition; earthquake
Mesh:
Substances:
Year: 2014 PMID: 25103146 PMCID: PMC4124816 DOI: 10.3402/gha.v7.24572
Source DB: PubMed Journal: Glob Health Action ISSN: 1654-9880 Impact factor: 2.640
Fig. 1Steps in HIV care process.
Fig. 2Conceptual model for factors associated with ART attrition.
Patient characteristics before and after 2010 earthquake at two hospitals in Haiti
| Overall | Before | After | ||||
|---|---|---|---|---|---|---|
|
| ||||||
|
| % |
| % |
| % | |
| All patients | 1,012 | 100.0 | 545 | 53.9 | 467 | 46.1 |
| Site | ||||||
| Jérémie | 534 | 52.8 | 299 | 54.9 | 235 | 50.3 |
| Jacmel | 478 | 47.2 | 246 | 45.1 | 232 | 49.7 |
| Gender | ||||||
| Male | 417 | 41.2 | 224 | 41.1 | 193 | 41.3 |
| Female (non-pregnant) | 529 | 52.3 | 287 | 52.7 | 242 | 51.8 |
| Female (pregnant) | 66 | 6.5 | 34 | 6.2 | 32 | 6.9 |
| Age group | ||||||
| <25 | 99 | 9.8 | 55 | 10.1 | 44 | 9.4 |
| 25–44 | 629 | 62.2 | 334 | 61.3 | 295 | 63.2 |
| ≥45 | 284 | 28.1 | 156 | 28.6 | 128 | 27.4 |
| Commune of residence | ||||||
| Same | 594 | 58.7 | 330 | 60.6 | 264 | 56.5 |
| Adjacent | 235 | 23.2 | 132 | 24.2 | 103 | 22.1 |
| Non-adjacent | 180 | 17.8 | 81 | 14.9 | 99 | 21.2 |
| Missing | 3 | 0.3 | 2 | 0.4 | 1 | 0.2 |
| BMI | ||||||
| <18.5 | 280 | 27.7 | 161 | 29.5 | 119 | 25.5 |
| 18.5+ | 642 | 63.4 | 338 | 62.0 | 304 | 65.1 |
| Missing | 90 | 8.9 | 46 | 8.4 | 44 | 9.4 |
| Baseline CD4 | ||||||
| <100 | 208 | 20.6 | 127 | 23.3 | 81 | 17.3 |
| 100–249 | 361 | 35.7 | 195 | 35.8 | 166 | 35.6 |
| 250+ | 312 | 30.8 | 157 | 28.8 | 155 | 33.2 |
| Missing | 131 | 12.9 | 66 | 12.1 | 65 | 13.9 |
| ART regimen | ||||||
| AZT-3TC-EFV | 542 | 53.6 | 264 | 48.4 | 278 | 59.5 |
| AZT-3TC-NVP | 376 | 37.2 | 223 | 40.9 | 153 | 32.8 |
| Other | 94 | 9.3 | 58 | 10.6 | 36 | 7.7 |
| WHO stage | ||||||
| Stage I or II | 644 | 63.6 | 352 | 64.6 | 292 | 62.5 |
| Stage III or IV | 347 | 34.3 | 181 | 33.2 | 166 | 35.6 |
| Missing | 21 | 2.1 | 12 | 2.2 | 9 | 1.9 |
| Any stage IV symptom | ||||||
| No | 803 | 79.4 | 456 | 83.7 | 347 | 74.3 |
| Yes | 209 | 20.7 | 89 | 16.3 | 120 | 25.7 |
| TB (treatment, prophylaxis, suspicion) | ||||||
| No | 882 | 87.2 | 480 | 88.1 | 402 | 86.1 |
| Yes | 130 | 12.9 | 65 | 11.9 | 65 | 13.9 |
| Pre-ART duration | ||||||
| <1 month | 390 | 38.5 | 213 | 39.1 | 177 | 37.9 |
| 1–6 months | 310 | 30.6 | 158 | 29.0 | 152 | 32.6 |
| >6 months | 312 | 30.8 | 174 | 31.9 | 138 | 29.6 |
| Counseling sessions | ||||||
| None | 585 | 57.8 | 322 | 59.1 | 263 | 56.3 |
| 1 | 340 | 33.6 | 193 | 35.4 | 147 | 31.5 |
| 2+ | 87 | 8.6 | 30 | 5.5 | 57 | 12.2 |
ART, antiretroviral therapy; AZT, zidovudine; BMI, body mass index; EFV, efavirenz; NVP, nevirapine; TB, tuberculosis; WHO, World Health Organization; 3TC, lamivudine.
p≤0.10,
p≤0.01,
p≤0.001.
Cases and rates of attrition, before and after 2010 earthquake at two hospitals in Haiti
| Attrition | Before | After | |||
|---|---|---|---|---|---|
|
| |||||
| Cases | Rate | 95% CI | Rate | 95% CI | |
| Overall | 172 | 30.0 | (24.8–36.2) | 23.0 | (18.0–29.2) |
| Site | |||||
| Jacmel | 54 | 23.1 | (16.8–31.8) | 12.5 | (7.7–20.4) |
| Jérémie | 118 | 35.9 | (28.3–45.5) | 31.4 | (23.8–41.4) |
| Gender | |||||
| Male | 73 | 31.1 | (23.0–41.9) | 24.7 | (17.3–35.4) |
| Female (non-pregnant) | 87 | 28.3 | (21.6–36.9) | 21.5 | (15.3–30.3) |
| Female (pregnant) | 12 | 37.1 | (19.3–71.3) | 23.7 | (7.6–73.4) |
| Age group | |||||
| <25 | 16 | 29.0 | (16.0–52.3) | 19.1 | (7.9–45.8) |
| 25–44 | 107 | 30.1 | (23.7–38.3) | 22.5 | (16.5–30.7) |
| ≥45 | 49 | 30.0 | (20.7–43.5) | 25.2 | (16.4–38.6) |
| Commune of residence | |||||
| Same as hospital | 70 | 18.9 | (14.1–25.4) | 16.4 | (11.1–24.0) |
| Adjacent to hospital | 47 | 37.9 | (26.7–54.0) | 25.9 | (15.8–42.2) |
| Non-adjacent | 54 | 77.0 | (53.8–110.1) | 36.4 | (24.4–54.3) |
| Missing | 1 | 368.9 | (52.0–2619.1) | 0.0 | |
| BMI | |||||
| <18.5 | 46 | 27.5 | (19.1–39.6) | 20.4 | (12.7–32.8) |
| 18.5+ | 108 | 27.5 | (21.4–35.4) | 26.1 | (19.6–34.7) |
| Missing | 18 | 60.0 | (36.7–97.9) | 8.4 | (2.1–33.7) |
| Baseline CD4 | |||||
| <100 | 25 | 17.8 | (10.9–29.1) | 17.6 | (9.1–33.8) |
| 100–249 | 61 | 26.6 | (19.1–37.0) | 25.9 | (17.6–38.1) |
| 250+ | 45 | 23.0 | (15.3–34.6) | 23.4 | (15.4–35.5) |
| Missing | 41 | 99.1 | (70.1–140.1) | 21.6 | (11.2–41.5) |
| ART regimen | |||||
| AZT-3TC-EFV | 83 | 29.6 | (22.3–39.3) | 21.3 | (15.3–29.6) |
| AZT-3TC-NVP | 76 | 32.7 | (24.8–43.2) | 25.2 | (17.2–37.0) |
| Other | 13 | 20.6 | (10.3–41.2) | 25.4 | (10.6–61.1) |
| WHO stage | |||||
| Stage I or II | 112 | 27.9 | (21.9–35.7) | 26.4 | (19.9–35.1) |
| Stage III or IV | 55 | 32.9 | (24.0–45.3) | 17.3 | (10.8–27.9) |
| Missing | 5 | 42.6 | (16.0–113.6) | 13.2 | (1.9–93.6) |
| Any WHO stage IV symptom | |||||
| No | 139 | 29.2 | (23.7–36.0) | 24.3 | (18.5–32.0) |
| Yes | 33 | 34.1 | (21.5–54.1) | 19.3 | (11.6–32.0) |
| TB (treatment, prophylaxis, suspicion) | |||||
| No | 156 | 30.7 | (25.1–37.5) | 24.3 | (18.9–31.3) |
| Yes | 16 | 24.5 | (13.2–45.6) | 14.8 | (6.6–32.9) |
| Pre-ART duration | |||||
| <1 month | 90 | 46.0 | (35.6–59.5) | 28.4 | (20.1–40.1) |
| 1–6 months | 41 | 21.6 | (14.3–32.5) | 20.1 | (12.6–31.9) |
| >6 months | 41 | 20.6 | (14.0–30.6) | 18.9 | (11.6–30.8) |
| Counseling sessions | |||||
| None | 108 | 31.8 | (25.1–40.1) | 25.4 | (18.5–34.9) |
| 1 | 55 | 28.8 | (20.6–40.3) | 21.2 | (13.9–32.6) |
| 2+ | 9 | 13.0 | (3.3–52.1) | 18.1 | (8.6–37.9) |
Rate per 100 person years; ART, antiretroviral therapy; AZT, zidovudine; BMI, body mass index; EFV, efavirenz; NVP, nevirapine; TB, tuberculosis; WHO, World Health Organization; 3TC, lamivudine.
Fig. 3ART attrition, before and after 2010 earthquake at two hospitals in Haiti.
Factors associated with ART attrition risk at two hospitals in Haiti
| Hazard ratio | 95% CI |
| |
|---|---|---|---|
| Site | |||
| Jacmel (post-quake vs. pre-quake) | 0.51 | (0.28–0.93) | 0.03 |
| Jérémie (post-quake vs. pre-quake) | 0.81 | (0.55–1.20) | 0.29 |
| Jacmel vs. Jérémie (pre-quake) | 0.55 | (0.35–0.86) | 0.01 |
| Jacmel vs. Jérémie (post-quake) | 0.35 | (0.19–0.65) | 0.001 |
| Gender (male=reference) | |||
| Female (non-pregnant) | 0.77 | (0.50–1.19) | 0.24 |
| Female (pregnant) | 0.91 | (0.44–1.88) | 0.79 |
| Age (10 year greater) | 1.07 | (0.92–1.25) | 0.39 |
| Proximity (same commune=reference) | |||
| Adjacent commune | 2.25 | (1.50–3.39) | <0.001 |
| Non-adjacent commune | 2.29 | (1.54–3.38) | <0.001 |
| BMI (<18.5=reference) | |||
| >18.5 | 1.13 | (0.76–1.66) | 0.55 |
| Baseline CD4 (<100=reference) | |||
| 100–200 | 1.44 | (0.81–2.56) | 0.20 |
| 200+ | 1.26 | (0.65–2.41) | 0.47 |
| ART regimen (AZT-3TC-EFV=reference) | |||
| AZT-3TC-NVP | 1.36 | (0.85–2.18) | 0.20 |
| Other regimen | 1.17 | (0.61–2.23) | 0.63 |
| WHO Stage (stage I or II=reference) | |||
| Stage III or IV | 1.05 | (0.74–1.50) | 0.78 |
| TB status (No suspicion, prophylaxis or diagnosis=reference) | |||
| Yes | 0.84 | (0.48–1.46) | 0.54 |
| Any stage IV symptom (No=reference) | |||
| Yes | 1.03 | (0.69–1.52) | 0.90 |
| Pre-ART duration (30 day increase) | 0.99 | (0.97–1.00) | 0.07 |
| Counseling sessions prior to ART start (None=reference) | |||
| 1 session | 0.92 | (0.65–1.30) | 0.64 |
| 2+ sessions | 0.49 | (0.24–1.00) | 0.05 |
Jacmel is the site closest to the earthquake epicenter while Jérémie is the site farther from the earthquake epicenter.
ART, antiretroviral therapy; BMI, body mass index; TB, tuberculosis; WHO, World Health Organization; ART regimen: AZT, zidovudine; 3TC, lamivudine; EFV, efavirenz; NVP, nevirapine.
p≤0.05,
p≤0.01,
p≤0.001.
Fig. 4Volume of HIV related services, before and after 2010 earthquake at two hospitals in Haiti.